Document Detail


Efficacy of catumaxomab in tumor spheroid killing is mediated by its trifunctional mode of action.
MedLine Citation:
PMID:  20652245     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Catumaxomab is an intact trifunctional bispecific antibody targeting human EpCAM (epithelial cell adhesion molecule) and CD3 with further binding to Fcgamma receptor type I, IIa and III. We choose multicellular tumor spheroids (MCTS) of human EpCAM-positive FaDu tumor cells in co-culture with human peripheral blood mononuclear cells as an adequate three-dimensional in vitro model for pharmacological testing of catumaxomab. We found a strong dose-dependent antitumor response mediated by catumaxomab, with volume-decreased or completely destroyed tumor spheroids together with a massive immune cell infiltration and decreased signals for cancer cell viability and clonogenicity. In control experiments with F(ab')2 fragments of catumaxomab and the parental antibodies alone or in combination the effects in spheroid volume reduction were less than that of catumaxomab. All binding partners of the postulated tricell complex have to be present to exert catumaxomab's full mode of action. These distinct effects of catumaxomab are based on the unique composition of the trifunctional bispecific antibody. Since, in general, many cancers are treated by chemotherapy in combination with immunological tumor therapy, we additionally analyzed the effects of cisplatin alone and in combination with catumaxomab. For cisplatin alone we detected a dose-dependent response relating to decrease of spheroid volume. The combined approach resulted in a synergistic spheroid volume decrease and the colony formation was reduced to non-detectable levels.
Authors:
Franziska Hirschhaeuser; Stefan Walenta; Wolfgang Mueller-Klieser
Related Documents :
7160585 - Combination therapy of murine tumors with lentinan plus lipopolysaccharide plus cycloph...
15383455 - Combination therapy for adult t-cell leukemia-xenografted mice: flavopiridol and anti-c...
6811485 - The influence of ascorbic acid on the growth of solid tumors in mice and on tumor contr...
10415735 - Broad antitumor and antiangiogenic activities of ag3340, a potent and selective mmp inh...
9258615 - Fine-needle sampling of salivary gland lesions. iv. review of 50 cases of mucoepidermoi...
16880505 - Genetic mechanisms for the synthesis of fucosyl gm1 in small cell lung cancer cell lines.
Publication Detail:
Type:  Journal Article     Date:  2010-07-21
Journal Detail:
Title:  Cancer immunology, immunotherapy : CII     Volume:  59     ISSN:  1432-0851     ISO Abbreviation:  Cancer Immunol. Immunother.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-08-30     Completed Date:  2010-09-21     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8605732     Medline TA:  Cancer Immunol Immunother     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  1675-84     Citation Subset:  IM    
Affiliation:
Institute of Physiology and Pathophysiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibodies, Bispecific / therapeutic use*
Antigens, CD3 / immunology*
Antigens, Neoplasm / immunology*
Antineoplastic Agents / therapeutic use
Carcinoma, Squamous Cell / immunology,  therapy*
Cell Adhesion Molecules / immunology*
Cell Survival
Cisplatin / therapeutic use
Coculture Techniques
Combined Modality Therapy
Head and Neck Neoplasms / immunology,  therapy*
Humans
Immunotherapy*
Spheroids, Cellular / immunology,  pathology*
Tumor Cells, Cultured
Tumor Stem Cell Assay
Chemical
Reg. No./Substance:
0/Antibodies, Bispecific; 0/Antigens, CD3; 0/Antigens, Neoplasm; 0/Antineoplastic Agents; 0/Cell Adhesion Molecules; 0/catumaxomab; 0/tumor-associated antigen GA733; 15663-27-1/Cisplatin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Generation of a tumor vaccine candidate based on conjugation of a MUC1 peptide to polyionic papillom...
Next Document:  Increased apelin serum levels and expression in human chondrocytes in osteoarthritic patients.